373 related articles for article (PubMed ID: 16292590)
1. The mGluR5 antagonist MPEP selectively inhibits the onset and maintenance of ethanol self-administration in C57BL/6J mice.
Hodge CW; Miles MF; Sharko AC; Stevenson RA; Hillmann JR; Lepoutre V; Besheer J; Schroeder JP
Psychopharmacology (Berl); 2006 Jan; 183(4):429-38. PubMed ID: 16292590
[TBL] [Abstract][Full Text] [Related]
2. The mGluR5 antagonist MPEP decreases operant ethanol self-administration during maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats.
Schroeder JP; Overstreet DH; Hodge CW
Psychopharmacology (Berl); 2005 Apr; 179(1):262-70. PubMed ID: 15717208
[TBL] [Abstract][Full Text] [Related]
3. Metabotropic glutamate receptor 5 activity in the nucleus accumbens is required for the maintenance of ethanol self-administration in a rat genetic model of high alcohol intake.
Besheer J; Grondin JJ; Cannady R; Sharko AC; Faccidomo S; Hodge CW
Biol Psychiatry; 2010 May; 67(9):812-22. PubMed ID: 19897175
[TBL] [Abstract][Full Text] [Related]
4. The mGluR5 antagonist MPEP suppresses the expression and reinstatement, but not the acquisition, of the ethanol-conditioned place preference in mice.
Lee JY; Choe ES; Yang CH; Choi KH; Cheong JH; Jang CG; Seo JW; Yoon SS
Pharmacol Biochem Behav; 2016 Jan; 140():33-8. PubMed ID: 26521964
[TBL] [Abstract][Full Text] [Related]
5. mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior.
Bäckström P; Bachteler D; Koch S; Hyytiä P; Spanagel R
Neuropsychopharmacology; 2004 May; 29(5):921-8. PubMed ID: 14735132
[TBL] [Abstract][Full Text] [Related]
6. Behavioral and neurochemical interactions between Group 1 mGluR antagonists and ethanol: potential insight into their anti-addictive properties.
Lominac KD; Kapasova Z; Hannun RA; Patterson C; Middaugh LD; Szumlinski KK
Drug Alcohol Depend; 2006 Nov; 85(2):142-56. PubMed ID: 16697125
[TBL] [Abstract][Full Text] [Related]
7. Metabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: relationship to acamprosate actions.
Blednov YA; Harris RA
Int J Neuropsychopharmacol; 2008 Sep; 11(6):775-93. PubMed ID: 18377703
[TBL] [Abstract][Full Text] [Related]
8. Differential modulation of ethanol-induced sedation and hypnosis by metabotropic glutamate receptor antagonists in C57BL/6J mice.
Sharko AC; Hodge CW
Alcohol Clin Exp Res; 2008 Jan; 32(1):67-76. PubMed ID: 18070246
[TBL] [Abstract][Full Text] [Related]
9. Regulation of motivation to self-administer ethanol by mGluR5 in alcohol-preferring (P) rats.
Besheer J; Faccidomo S; Grondin JJ; Hodge CW
Alcohol Clin Exp Res; 2008 Feb; 32(2):209-21. PubMed ID: 18162077
[TBL] [Abstract][Full Text] [Related]
10. mGlu5 receptors are involved in the discriminative stimulus effects of self-administered ethanol in rats.
Besheer J; Stevenson RA; Hodge CW
Eur J Pharmacol; 2006 Dec; 551(1-3):71-5. PubMed ID: 17026991
[TBL] [Abstract][Full Text] [Related]
11. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles.
Varty GB; Grilli M; Forlani A; Fredduzzi S; Grzelak ME; Guthrie DH; Hodgson RA; Lu SX; Nicolussi E; Pond AJ; Parker EM; Hunter JC; Higgins GA; Reggiani A; Bertorelli R
Psychopharmacology (Berl); 2005 Apr; 179(1):207-17. PubMed ID: 15682298
[TBL] [Abstract][Full Text] [Related]
12. Combined antagonism of glutamate mGlu5 and adenosine A2A receptors interact to regulate alcohol-seeking in rats.
Adams CL; Cowen MS; Short JL; Lawrence AJ
Int J Neuropsychopharmacol; 2008 Mar; 11(2):229-41. PubMed ID: 17517168
[TBL] [Abstract][Full Text] [Related]
13. The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice.
Paterson NE; Semenova S; Gasparini F; Markou A
Psychopharmacology (Berl); 2003 May; 167(3):257-64. PubMed ID: 12682710
[TBL] [Abstract][Full Text] [Related]
14. Cue-induced reinstatement of alcohol-seeking behavior is associated with increased ERK1/2 phosphorylation in specific limbic brain regions: blockade by the mGluR5 antagonist MPEP.
Schroeder JP; Spanos M; Stevenson JR; Besheer J; Salling M; Hodge CW
Neuropharmacology; 2008 Sep; 55(4):546-54. PubMed ID: 18619984
[TBL] [Abstract][Full Text] [Related]
15. The mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine decreases ethanol consumption via a protein kinase C epsilon-dependent mechanism.
Olive MF; McGeehan AJ; Kinder JR; McMahon T; Hodge CW; Janak PH; Messing RO
Mol Pharmacol; 2005 Feb; 67(2):349-55. PubMed ID: 15548766
[TBL] [Abstract][Full Text] [Related]
16. The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse.
McGeehan AJ; Olive MF
Synapse; 2003 Mar; 47(3):240-2. PubMed ID: 12494407
[TBL] [Abstract][Full Text] [Related]
17. Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats.
Bespalov AY; Dravolina OA; Sukhanov I; Zakharova E; Blokhina E; Zvartau E; Danysz W; van Heeke G; Markou A
Neuropharmacology; 2005; 49 Suppl 1():167-78. PubMed ID: 16023685
[TBL] [Abstract][Full Text] [Related]
18. Assessing appetitive and consummatory phases of ethanol self-administration in C57BL/6J mice under operant conditions: regulation by mGlu5 receptor antagonism.
Cowen MS; Krstew E; Lawrence AJ
Psychopharmacology (Berl); 2007 Jan; 190(1):21-9. PubMed ID: 17096086
[TBL] [Abstract][Full Text] [Related]
19. Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking.
Tessari M; Pilla M; Andreoli M; Hutcheson DM; Heidbreder CA
Eur J Pharmacol; 2004 Sep; 499(1-2):121-33. PubMed ID: 15363959
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of behavioral effects of cocaine by the Metabotropic Glutamate Receptor 5 Antagonist 2-Methyl-6-(phenylethynyl)-pyridine in squirrel monkeys: comparison with dizocilpine.
Lee B; Platt DM; Rowlett JK; Adewale AS; Spealman RD
J Pharmacol Exp Ther; 2005 Mar; 312(3):1232-40. PubMed ID: 15550570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
